Stockholm Stock Exchange | Mid Cap
Oncopeptides
+12.70%
Latest
+12.70%
3 months
DNBCarnegieDNB MarketsABG Sundal CollierKempenSEB Equities

Price Targets For Oncopeptides

AnalystPrice TargetDateUpside
DNB5.5 SEKFeb 28
+12.70%
Carnegie6.8 SEKNov -23
DNB Markets15 SEKMay -23
ABG Sundal Collier12 SEKSep -22
Kempen35 SEKJul -22
SEB Equities0.35 SEKOct -21

About The Company

Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode's shares have been listed on the Stockholm Stock Exchange's main list since 2017.
Wikipedia